INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Corporate insider
EK

Equels Thomas K

Director, CEO & PresidentCIK 0001450324

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells2 / 0
Max Insider Score37
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
33
EK
Equels Thomas KDirector, CEO & President
AIMAIM ImmunoTech Inc.
Open-market purchase
BUY$5,068
31.7K sh
Oct 23, 2026Oct 26, 2026
traded Oct 23, 2026
+3dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    AIM ImmunoTech Inc.Director, CEO & President · Oct 23, 2026
37
EK
Equels Thomas KDirector, CEO & President
AIMAIM ImmunoTech Inc.
Open-market purchase
BUY
$5,094
31.3K sh
Oct 22, 2026
Oct 23, 2026
traded Oct 22, 2026
+1d
SEC FORM 4

Evidence